Dublin, Oct. 09, 2020 (GLOBE NEWSWIRE) — The “CBD Oil & CBD Consumer Health Market Size, Share & Trends Analysis Report by Product, by Distribution Channel, by Region (North America, Europe, Asia Pacific, Latin America, MEA), and Segment Forecasts, 2020 – 2027” report has been added to ResearchAndMarkets.com’s offering.
The global CBD oil and CBD consumer health market size is expected to reach USD 123.2 billion by 2027, expanding at a CAGR of 25.6% over the forecast period.
Growing buyer awareness regarding various health benefits offered by cannabidiol (CBD) and increasing legalization of cannabidiol oil and infused products is contributing towards the adoption of cannabidiol as a consumer health product, thereby positively impacting the market growth. Furthermore, changing buyer perception and attitude towards hemp-derived cannabidiol-based products is further bolstering revenue growth over the forecast period.
Based on the type of product, the full spectrum oil segment dominated the market in 2019. Factors contributing to the increase in demand for cannabidiol include rising buyer preference toward cannabidiol as a product category, the surge in demand for full-spectrum distillates, and many companies entering into bulk as well as finished product business.
On the other hand, the nutraceuticals segment dominated the market with a share of 48.3% in 2019. Favorable government initiatives for hemp-derived cannabidiol, rising awareness regarding cannabidiol, and changing buyer preferences from chemical-based ingredients to organic ingredients in dietary supplements are the key factors driving the market.
In 2019, the B2B distribution channel segment accounted for the highest revenue share in the market. This growth is attributed to the increase in demand for cannabidiol oil in various sectors such as pharmaceutical, food and additives, health and wellness, and cosmetics. On the other hand, retail pharmacies dominated the market in 2019. The increase in the number of companies selling their products via retail pharmacies is fueling the growth of the segment.
North America dominated the market with a revenue share of 68.5% in 2019 owing to ease of accessibility, growing awareness regarding various medical benefits of cannabidiol among users, and the rise in the number of manufacturers.
CBD Oil & CBD Consumer Health Market Report Highlights
- The increasing legalization of cannabidiol based products and increasing adoption of cannabidiol as consumer products are anticipated to propel market growth.
- The cannabidiol oil segment dominated the market in 2019, owing to the surge in demand for full-spectrum products.
- Nutraceuticals dominated the market in 2019 with a share of 48.3%, owing to the rise in user shift from chemical-based ingredients to organic and herbal ingredients in dietary supplements.
- The B2B distribution channel segment dominated the market in 2019, owing to the increase in demand for cannabidiol based products in various sectors such as pharmaceutical, food and additives, health and wellness, and cosmetics.
- The retail pharmacies segment dominated the market with a revenue share of 40.7% in 2019, owing to exclusive collaborations of companies with retail pharmacies.
- North America dominated the market with a revenue share of 68.5% in 2019, owing to ease of accessibility, increase in awareness about cannabidiol, and legalization of medical cannabis in the region.
Key Topics Covered:
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Global CBD Oil Market Outlook, Estimates, Forecasts & Trend Analysis
3.1 CBD Oil Market: Variables, Trends & Scope
3.1.1 Market Segmentation (Global Cannabidiol (CBD) Consumer Health Market)
3.1.2 Penetration & Growth Prospect Mapping
3.1.3 Cannabis Regulatory Scenario, By Country
3.1.4 Market Dynamics
22.214.171.124 Market Driver Analysis
126.96.36.199.1 Growing legalization of cannabis-based CBD
188.8.131.52.2 Growing adoption of CBD-based products for treating various medical conditions
184.108.40.206.3 Growing number of companies producing Synthetic CBD for pharmaceutical applications
220.127.116.11 Market Restraint Analysis
18.104.22.168.1 Strict government regulations pertaining to production and distribution of CBD products
22.214.171.124 Industry Challenges
3.1.5 COVID-19 Impact Analysis (Current & Future)
3.1.6 CBD Oil- Porter’s Analysis
3.1.7 Cannabidiol (CBD)-PESTEL Analysis
3.1.8 Opportunity Analysis (2016-2020-2027)
3.1.9 Product Life Cycle Analysis, by Finished Product, By Country
3.1.10 Product Adoption Pattern Analysis
126.96.36.199 Full Spectrum CBD Oil
188.8.131.52 CBD Isolate
184.108.40.206 Synthetic CBD
3.1.11 Supply Chain Analysis
3.1.12 Market price evolution of biomass commodity cost (to processor/CBD manufacturer)
3.1.13 Manufacturing Trends/ Technology Adoptions Trends
3.1.14 Exhaustive list of Producers/Manufacturers by Country
3.2 Product Type Market Revenue Size, Forecasts and Trend Analysis, 2016 To 2027
3.2.1 CBD Oil Market: Product Type Analysis
220.127.116.11 Product Type Movement Analysis, Revenue (USD Million)
18.104.22.168 CBD Oil
22.214.171.124.1 Global CBD Oil market, 2016-2027 (USD Million)
126.96.36.199 CBD Isolate
188.8.131.52.1 Global CBD Isolate market, 2016-2027 (USD Million)
184.108.40.206 Synthetic CBD
220.127.116.11.1 Global synthetic CBD market, 2016-2027 (USD Million)
3.3 Distribution Channel Market Revenue Size, Forecasts and Trend Analysis, 2016 To 2027
3.4 CBD Oil Market: Distribution Channel Analysis
3.5 Distribution Channel Movement Analysis, Revenue (USD Million)
18.104.22.168 Global B2B market, 2016-2027 (USD Million)
22.214.171.124 Pharma Manufacturers
126.96.36.199.1 Global pharma manufacturers market, 2016-2027 (USD Million)
188.8.131.52 Consumer Goods Manufacturers
184.108.40.206.1 Global consumer goods manufacturers market, 2016-2027 (USD Million)
220.127.116.11 Nutraceutical Manufacturers
18.104.22.168.1 Global Nutraceutical manufacturers market, 2016-2027 (USD Million)
22.214.171.124.1 Global other manufacturers market, 2016-2027 (USD Million)
126.96.36.199 Global B2C market, 2016-2027 (USD Million)
Chapter 4 Global CBD Consumer Health Products Market Outlook, Estimates & Trend Analysis
4.1 CBD Consumer Health Products Market: Variables, Trends & Scope
4.1.1 Market Segmentation (Global Cannabidiol (CBD) Consumer Health Market)
4.1.2 Penetration & Growth Prospect Mapping
4.1.3 CBD Infused Products Regulatory Scenario, By Country
4.1.4 Market Dynamics
188.8.131.52 Market Driver Analysis
184.108.40.206.1 Cannabis revolution positively impacting consumer health market
220.127.116.11.2 Consumer perception and attitude toward CBD products
18.104.22.168.3 Rise in the number of retailers selling CBD-based products
22.214.171.124.4 Increasing demand for CBD nutraceuticals
126.96.36.199.5 Growing adoption of CBD topicals across the world
188.8.131.52.6 Rise in disposable income influencing CBD products demand
184.108.40.206 Market Restraint Analysis
220.127.116.11.1 Availability of alternatives to CBD supplements
18.104.22.168.2 High price of CBD products
22.214.171.124.3 Presence of counterfeit products
126.96.36.199 Industry Challenges
188.8.131.52.1 Uncertain government regulations related to CBD and CBD products
4.1.5 Covid-19 Impact Analysis
4.1.6 Cannabidiol (CBD) Consumer Health-Porter’s Analysis
4.1.7 Cannabidiol (CBD) Consumer Health-PESTEL Analysis
4.1.8 Opportunity Analysis (2016-2020-2027)
4.1.9 Product Adoption Pattern Analysis
184.108.40.206 CBD Medical Products
220.127.116.11 CBD Nutraceuticals
18.104.22.168 Personal Care & Cosmetics
4.1.10 Supply Chain Analysis (CBD Oil & CBD Consumer Health)
22.214.171.124 Supply Chain Analysis-CBD Consumer Health Product
126.96.36.199 Profit Margin Estimation
188.8.131.52 Case Study: Medical Marijuana, Inc.
184.108.40.206 Case Study: Isodiol International Inc.
220.127.116.11 Raw Material Trends
4.1.11 Market Price Evolution of Biomass Commodity Cost (To Processor/CBD Manufacturer)
4.1.12 Market Price Evolution (Raw Material to Finished Goods)
4.1.13 Manufacturing Trends/ Technology Adoptions Trends
4.1.14 Manufacturing Trends (Finished Goods)
4.1.15 Interdependency Analysis
4.1.16 Effects of Consolidation on the Value Chain
4.1.17 Exhaustive list of Producers/Manufacturers by Country
4.2 Product Type Market Revenue Size, Forecasts and Trend Analysis, 2016 To 2027
4.2.1 Cannabidiol (CBD) Consumer Products Market: Product Type Analysis
4.2.2 Product Type Movement Analysis, Revenue (USD Million)
18.104.22.168 Medical Products
22.214.171.124.1 Global OTC Medical Products market, 2016-2027 (USD Million)
126.96.36.199.2 CBD Analgesic Products
188.8.131.52.3 CBD Mental Health Products
184.108.40.206.4 CBD Dermatology Products
220.127.116.11.5 CBD Sleep Aids Products
18.104.22.168.6 Other OTC products
22.214.171.124.1 Global nutraceuticals market, 2016-2027 (USD Million)
126.96.36.199.2 CBD Vitamins and Dietary Supplements
188.8.131.52.3 CBD Sports Nutrition
184.108.40.206.4 CBD Weight Management and Wellbeing
220.127.116.11 Food & Beverages
18.104.22.168 Personal Care & Cosmetic Products
22.214.171.124.1 Global personal care & cosmetic products market, 2016-2027 (USD Million)
126.96.36.199.2 CBD Infused Skincare Products
188.8.131.52.3 CBD Infused Beauty Products
184.108.40.206.4 CBD Infused Haircare Products
4.3 Distribution Channel Market Revenue Size, Forecasts and Trend Analysis, 2016 To 2027
4.3.1 Cannabidiol (CBD) Consumer Products Market: Distribution Channel Analysis
4.3.2 Distribution Channel Movement Analysis, Revenue (USD Million)
220.127.116.11 Retail Stores
18.104.22.168 Retail Pharmacies
- CV Sciences, Inc.
- Medical Marijuana Inc.
- CHARLOTTE’S WEB
- NuLeaf Naturals, LLC
- JOY Organics
- Lord Jones
- Aurora Cannabis
- Canopy Growth Corporation
- Global Cannabinoids inc.
- cbd american shaman.
- BioVectra inc.
- Bluebird Botanicals
- cure pharmaceutical.
- GW Pharmaceuticals, plc.
- THC Pharm Gmbh
For more information about this report visit https://www.researchandmarkets.com/r/sforax
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Greene Concepts Fortifies Financial Positioning Through Major Debt Reduction Combined with Share Buyback in Alignment with the Company’s Growth Strategy
Marion, North Carolina–(Newsfile Corp. – October 28, 2020) – Greene Concepts Inc. (OTC Pink: INKW) is excited to report the company has completed a debt forgiveness agreement in the amount of $340,898 previously owed to one of our largest note holders. This reduces our notes payable by 56%. The debt holder, Greene Concepts’ management and accountants have agreed to write-off and eliminate $340,898 of the third-party convertible notes from the company’s finances as debts that are no longer due.
Additionally, the Company is in the process of finalizing a substantial share buyback of its common stock. This common stock buyback will reduce the common share count by over 280 million shares. The company has taken powerful actions financially in a short time span by increasing its Assets, Cash, Inventory, and Sales.
|Greene Concepts 3rd and 4th Quarter Finance Comparisons|
|3rd Quarter Report (Period Ending 4/30/2020)||4th Quarter Annual Report (Period Ending 7/31/2020)|
Lenny Greene, CEO of Greene Concepts notes, “Today’s announcement marks an important step forward in significantly strengthening Greene Concepts in terms of debt reduction which wipes out 56% of our debt (over $340,000 worth of payable debt) off our books. We would like to give a profound thanks to this Debt holder for their strong work and altruism in this action. This bold and forward-looking gesture better positions us for increased revenue generation, faster inventory turnaround times, increased gross and profit margins, a rise in working capital, employee additions and positive cash flows. It also allows us to increase our assets, our cash reserves, and our total sales. We will continue to focus on the things we can control with aggressive cost management and working capital reductions. This focus will allow us to reduce debt, achieve positive liquidity and balance sheet improvement.”
Mr. Greene continues, “We are pleased to continue making strides in our ongoing efforts to strengthen our business, increase our flexibility and improve returns on capital. It is our intention to do whatever we can to continually reduce our debt and monitor our Key Performance Indicators for our financial condition to include our cash, accounts receivable and accounts payable. While we amplify our sales and reduce our debt, we also maintain an inventory of $51,425 of cases of our bottled ‘Be Water’ Brand ready to ship to Amazon and throughout the country. Our new ‘Be Water’ Label production run begins next week.”
BeWater New Label
To view an enhanced version of this graphic, please visit:
“Finally, we are in the process of finalizing a share buyback of our stock. This common share buyback will reduce our common share count by over 280 million shares. We are confident that each of these financial actions offer improved security during these uncertain times and better positions us to pull the trigger on future partnership or acquisition opportunities while preparing us for unprecedented growth.”
Greene Concepts Creek Running Water
To view an enhanced version of this graphic, please visit:
About Greene Concepts, Inc., Mammoth Ventures, Inc. and Water Club, Inc.
Greene Concepts, Inc. (http://www.greeneconcepts.com) is a publicly traded company. Through its recently acquired wholly owned subsidiary, Mammoth Ventures Inc., the Company has entered the specialty beverage and bottling business and is an emerging leader in the global scientifically formulated beverage industry. Through its subsidiary Water Club, Inc. we intend to pursue subscription-based delivery of water and scientifically formulated beverages directly to the consumers home and market the convenience of this service thru social media affiliate marketing partners.
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Greene Concepts, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/67028
TransGlobal Assets Inc. (TMSH) Expands in Pittsburgh Area with Property Acquisition
Company seeks a foothold on manufacturing of Monster Elixir branded CBD products and beverages
Pittsburgh, Pennsylvania–(Newsfile Corp. – October 28, 2020) – TransGlobal Assets, Inc. (OTC Pink: TMSH) is proud to announce the purchase of a 3,500 square foot building in Pittsburgh that will serve as the headquarters of Monster Elixir Inc., a wholly-owned subsidiary. It will house manufacturing for Monster Elixir’s line of CBD beverages and topical healing products.
To view an enhanced version of this graphic, please visit:
The purchase expands on the company’s growth plan, which currently features a 2,400 square foot rental space in the city that will be a storage unit for production. The plan also entails the purchase of the first of many additional store front retail spaces in the Pittsburgh area.
The company is securing space for its line of heavily demanded drinks called Green Essence Beverages. The CBD-infused drinks will be sold in the following flavors:
Pineapple Agave (Dark)
Strawberry Pineapple Lemonade
Monster Elixir will also launch a line of CBD wellness products that include, but are not limited to, the following:
Joint & Muscle Cream
Joint & Muscle Balm
In addition, the company is also launching a line of hemp-infused hair care products that will include shampoos & conditioners, healthy hair butters & tinctures, as well as beard care products. These fine CBD products will be sold at local dispensaries and other retail outlets.
For further inquiries please contact:
Curtis Philpot CEO
TransGlobal Assets Inc.
Office: (833) 217-8764
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/67026
Hemp, Inc. Set to Distribute Full King of Hemp® Product Line Across Country
Las Vegas, NV, Oct. 28, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers, announced today it will be aggressively shipping its King of Hemp® product line to stores across the country over the next 30-60 days. To date, the King of Hemp® product line consists of Bubba Kush hemp; Pre-rolls, Fortified Pre-rolls, Caviar/Moon Rocks; and Diamonds.
According to Bruce Perlowin, CEO of Hemp, Inc., the Company is revving up to launch one of its most aggressive marketing campaigns to date. “Our number one goal has been to produce top-of-the-line CBD and CBG smokable products and CBD consumption options that fit consumer lifestyles and deliver unparalleled results. We’ve done just that with the King of Hemp® line.”
Hemp, Inc.’s Diamonds and Crumbles (smaller Diamond pieces) are dabbable CBD products, derived from a golden-hued high CBD, THC-free distillate taken directly from the hemp plant that includes blends of valuable terpenes. Diamonds and Crumbles promise to deliver the strongest, most potent effects of any other product from the line containing between 92% and 98.7% pure CBD.
Consumption methods include, but are not limited to, utilizing a dab rig or a wax vaporizer for the fastest, strongest results. (While Hemp, Inc. does not cultivate, manufacture or produce any type of THC product, consumers of the Company’s CBD product Diamonds report that mixing Diamonds with a THC concentrate helps to mellow THC’s effects).
“Diamonds or Crumbles are the perfect way for our customers to get a pure, clean CBD dabbing experience with instant results that last,” said Perlowin.
Hemp, Inc.’s Caviar, similar to Moon Rocks, is a highly potent and rich tasting smokable product with less than 0.3% THC. It is made from Hemp, Inc.’s high-quality Southern Oregon-grown Bubba Kush hemp flower, which is covered with a THC-Free distillate (with and without added terpenes), and then rolled in CBG-rich kief. The product contains over 45% CBD and over 10% CBG.
Many people prefer to smoke their hemp products due to the speed and effectiveness of the delivery system. By entering the body through the respiratory system, there is a dramatic increase in bioavailability as compared to oral consumption. It is the fastest way to receive CBD and CBG’s potential calming and pain-relieving benefits.
Consumption methods include but are not limited to vaporizing Caviar in an all-ceramic or stainless steel vaporizer to capture the full terpene profile and cannabinoid effects; or using a glass water pipe. While Caviar is not a cannabis product, smoking it the way hash is smoked is recommended to achieve the best results.
“Caviar exemplifies the variety of ways consumers can enjoy CBD and CBG and reflects our brand vision of providing a superior, royal experience,” said Perlowin.
The King of Hemp® pre-roll line offers high-end products that are an effective and flavorful, smokable alternative to cigarettes and other hemp consumption methods. The King of Hemp® pre-rolls can be purchased individually or in packs of 6. Each pre-roll is 1 gram and does not exceed 0.3% THC.
King of Hemp® pre-rolls use A and B hemp colas which are derived from Pre-98 OG Bubba Kush hemp, one of the top selling cultivars on the market. The strain, rich soil and climate lend themselves to these colas being among the highest quality buds, positioning them to be some of the best tasting for consumption.
The Company’s website for its King of Hemp® line (www.kingofhempusa.com) also has CBD oil tinctures available for purchase. The tinctures are available in two flavors, Natural and Peppermint, and contain full-spectrum hemp oil extracted from the flowers and leaves of hemp plants sustainably sourced from Colorado. They are also compliant with the regulations created by the Colorado Department of Agriculture in regards to industrial hemp. The tinctures contain 0.3% or less THC and are compliant with the 2018 Farm Bill.
To learn more, go to the King of Hemp® website, here.
According to Nielsen, market researchers project 2020 sales in the current smokable-hemp market to reach $70 million to $80 million. This category includes loose CBD flower, hemp-CBD pre-rolls, cigars and other inhalables.
To see one-minute videos of Hemp, Inc.’s current activities, visit Bruce Perlowin’s personal Facebook fan page, where he shares posts of Hemp, Inc.’s activities around the country. Additionally, follow Hemp, Inc. on Instagram here and on Twitter here.
To view the webinar featuring Hemp, Inc.’s CEO, Bruce Perlowin, click here.
WHAT IS HEMP, INC.?
What is Hemp, Inc.? With a deep-rooted social and environmental mission at its core, Hemp, Inc. seeks to build a business constituency for the American small hemp farmer, the American veteran, and other groups experiencing the ever-increasing disparity between tapering income and soaring expenses. The Company is on a mission to be a powerful engine for social change and economic revival, worldwide, by providing hemp products that are eco-friendly, sustainable and healthy. Hemp, Inc. executives believe there can be tangible benefits reaped from adhering to a corporate social responsibility plan.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. The Securities and Exchange Commission (SEC) requires issuers to provide “adequate current information” and Hemp, Inc. does… using the SEC’s Alternative Reporting Standard to publicly report its quarterly and yearly financials. All current information can be found on www.hempinc.com/hemp-financial-disclosures/. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
Cannabis4 weeks ago
MustGrow Commences Banana ‘Panama Disease’ Testing in Colombia
Cannabis3 weeks ago
Bud & Tender® raise testing and quality standards for best CBD oil in the UK
Cannabis3 weeks ago
The World’s Greatest Weight Loss Secret May be Psilocybin
Cannabis2 weeks ago
Aither Ingredients Announces Joint Venture With Thar Process Intended to Disrupt the Canadian Cannabis-based Ingredient Market
Cannabis4 weeks ago
WeedMD Reports Second Quarter 2020 Financial Results and Closes $30 Million Credit Facility with LiUNA Pension Fund
Cannabis4 weeks ago
PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND
Cannabis4 weeks ago
Christina Lake Announces Commencement of Trading on the CSE
Cannabis2 weeks ago
IGNITE Files Q2 2020 Financial Statements and MD&A